Financials in USD. Standardized financial statements.
A compact view of how Deltex Medical Group plc turns revenue into operating income and net income.
| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $2.06M | $1.78M | $2.48M | $2.26M | $2.40M | $4.26M | $4.96M | $5.87M | $6.33M | $6.41M |
| Revenue Growth? | +15.8% | -28.4% | +9.9% | -5.8% | -43.7% | -14.1% | -15.6% | -7.3% | -1.2% | 0.0% |
| Cost of Revenue? | $658,000 | $651,000 | $643,000 | $684,000 | $757,000 | $974,000 | $1.42M | $1.49M | $2.00M | $2.40M |
| Gross Profit? | $1.40M | $1.13M | $1.84M | $1.57M | $1.64M | $3.28M | $3.53M | $4.38M | $4.33M | $4.01M |
| Gross Margin? | +68.0% | +63.3% | +74.1% | +69.7% | +68.4% | +77.1% | +71.3% | +74.7% | +68.4% | +62.6% |
| Operating Expenses? | $2.98M | $2.18M | $2.82M | $2.44M | $2.21M | $3.18M | $4.44M | $6.32M | $6.70M | $7.34M |
| Operating Income? | -$1.59M | -$1.05M | -$947,000 | -$805,000 | -$622,000 | -$34,000 | -$1.15M | -$1.94M | -$2.37M | -$3.49M |
| EBITDA? | -$807,000 | -$919,000 | -$819,000 | -$691,000 | -$480,000 | $196,000 | -$740,000 | -$1.49M | -$1.96M | -$3.09M |
| Income Before Tax | -$1.80M | -$1.28M | -$1.15M | -$978,000 | -$794,000 | -$210,000 | -$1.34M | -$2.10M | -$2.52M | -$3.60M |
| Income Tax Expense | $0 | $0 | -$1,000 | -$12,000 | -$9,000 | -$51,000 | -$74,000 | -$100,000 | -$142,000 | -$135,000 |
| Net Income? | -$1.80M | -$1.28M | -$1.15M | -$966,000 | -$785,000 | -$159,000 | -$1.26M | -$2.00M | -$2.38M | -$3.46M |
| EPS? | $-0.00 | $-0.00 | $-0.00 | $-0.00 | $-0.00 | $-0.00 | $-0.00 | $-0.01 | $-0.01 | $-0.02 |
| Diluted EPS? | $-0.00 | $-0.00 | $-0.00 | $-0.00 | $-0.00 | $-0.00 | $-0.00 | $-0.01 | $-0.01 | $-0.02 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality